近年来,糖尿病人存在血小板功能的异常已得到一致公认。有报告证明,糖尿病人血小板活性增高,在有微血管或阻塞性血管并发症的病人表现特别明显。我们以往的报告初步肯定了达美康的降糖作用,同时指出此药还有减低血小板粘附的作用。但有人提出这种作用在治疗过程中不够稳定。为了探讨本药对血小板功能的影响是否随治疗时间的延长而持续存在,我们对10例 In recent years, abnormalities in the presence of platelet function in diabetic patients have been universally acknowledged. There are reports that increased platelet activity in diabetic patients, particularly in patients with microvascular or obstructive vascular complications. Our previous report initially confirmed the hypoglycemic effect of dumecone, also pointed out that the drug also has the effect of reducing platelet adhesion. However, it was suggested that this effect is not stable enough during treatment. In order to explore whether the effect of this drug on platelet function continues with the extension of treatment time, we have 10 cases